Aline Charabaty Pishvaian MD, FACG, AGAF

Aline Charabaty Pishvaian, MD, AGAF, FACG, is Professor of Medicine at the University of Maryland and the Director of the Center for Inflammatory Bowel Disease at the University of Maryland Medical Center, where she leads initiatives focused on clinical excellence and innovation, improving access to care, promoting patient-centered clinical research, and advancing medical education in IBD.

A board-certified gastroenterologist specializing in Inflammatory Bowel Disease (IBD), Dr. Charabaty is a nationally and internationally recognized clinician, educator, and innovator. She joined the University of Maryland in 2026, after a distinguished tenure as the Director of the IBD Center at Georgetown University Hospital, where she established a multidisciplinary IBD Center, and at Johns Hopkins School of Medicine, where she served as the Medical Director of the Division of Gastroenterology and Hepatology of the Johns Hopkins-Sibley Memorial Hospital in Washington DC and implemented and led a comprehensive IBD Center.

Dr. Charabaty earned her B.S in Human Genetics at McGill University, Canada, and pursued her MD degree at the School of Medicine of Saint Joseph University, Lebanon, before completing her residency in Internal Medicine and fellowship in Gastroenterology and Hepatology at Georgetown University Hospital in Washington DC.

Dr Charabaty was selected to complete the Advanced Leadership Program offered by the American College of Gastroenterology Leadership, Ethics and Equity Center, and received the Healio Disruptive Innovator Award in 2019 for the educational @MondayNightIBD platform she founded, the ACG Service Award for Colorectal Outreach, Prevention and Year-round excellence (SCOPY) in 2020, the Crohn’s and Colitis Foundation Excellence in Medicine Award in 2020, the ACG Governor Award for Advocacy on Social Media in 2022, the ACG Award for Championing Women in GI in 2024 and the ACG Diversity, Equity and Inclusion Award in 2025.